Evaluation of clinical features and treatment modality of pediatric patients with Steven Johnson syndrome/toxic epidermal necrolysis: a single-center experience
Turkish Journal of Medical Sciences · 17.04.2025 · 55 (2) · 461-469
DOI: 10.55730/1300-0144.5990 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 17.04.2025. Verfasst von Funda Aytekin Güvenir und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Allergy and Immunology, Department of Pediatrics, Ankara Bilkent City Hospital, Ankara, Turkiye. Hauptthemen laut MEDLINE: Stevens-Johnson Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aim: Steven Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are rare but life-threatening severe cutaneous drug hypersensitivity reactions. The aim of our study was to evaluate the clinical features of pediatric patients diagnosed with SJS, TEN or SJS/TEN overlap and to examine treatment modalities. Materials and methods: Patients aged 0–18 years who were followed up with SJS, TEN or SJS/TEN overlap at Ankara Bilkent City Hospital between August 2019 and January 2024 were retrospectively analyzed.
Results
Twelve patients who met the inclusion criteria were included in the study. Five of the patients had SJS, four had SJS/TEN overlap, and three had TEN. Eight of the patients were female, and the median age at presentation was 10.5 (IQR:6–16) years. Ten of the patients had a history of drug use. Eight patients had antibiotics, two had proton pump inhibitors, two had allopurinol, and two had antiepileptic (lamotrigine and valproic acid) use. All 12 patients received IVIG and systemic steroid therapy. Three TEN and four SJS/ TEN overlap patients received cyclosporine. Two TEN patients underwent plasmapheresis. The most common long-term sequelae were dermatological sequelae.
Conclusion
SJS/TEN patients should be monitored with a multidisciplinary approach, and if necessary, in the burn intensive care unit. Primary treatment is supportive care. Early initiation of cyclosporine may have a positive effect on the prognosis in patients with SJS/ TEN overlap and TEN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Allergy and Immunology, Department of Pediatrics, Ankara Bilkent City Hospital, Ankara, Turkiye.
- Department of Pediatric Surgery, Ankara Bilkent City Hospital, Ankara, Turkiye.
- Division of Pediatric Intensive Care, Department of Pediatrics, Ankara Bilkent City Hospital, Ankara, Turkiye.
ORCID-Profile: Funda Aytekin Güvenir, Vildan Selin Çayhan, Selman Kürşat Balci, Ragıp Dere, Hatice Irmak Çelik, Serhat Emeksiz, Ahmet Selmanoğlu, Zeynep Şengül Emeksiz, Emrah Şenel, Emine Dibek Misirlioğlu
Zitieren
APA
Güvenir, F. A., Çayhan, V. S., Balci, S. K., Dere, R., Çelik, H. I., Emeksiz, S., Selmanoğlu, A., Emeksiz, Z. Ş., Şenel, E., & Misirlioğlu, E. D. (2025). Evaluation of clinical features and treatment modality of pediatric patients with Steven Johnson syndrome/toxic epidermal necrolysis: a single-center experience. Turkish Journal of Medical Sciences, 55(2), 461-469. https://doi.org/10.55730/1300-0144.5990
Vancouver
Güvenir FA, Çayhan VS, Balci SK, Dere R, Çelik HI, Emeksiz S, et al. Evaluation of clinical features and treatment modality of pediatric patients with Steven Johnson syndrome/toxic epidermal necrolysis: a single-center experience. Turkish Journal of Medical Sciences. 2025;55(2):461-469. doi:10.55730/1300-0144.5990
BibTeX
@article{Gvenir2025,
author = {Güvenir, Funda Aytekin and Çayhan, Vildan Selin and Balci, Selman Kürşat and Dere, Ragıp and Çelik, Hatice Irmak and Emeksiz, Serhat and Selmanoğlu, Ahmet and Emeksiz, Zeynep Şengül and Şenel, Emrah and Misirlioğlu, Emine Dibek},
title = {Evaluation of clinical features and treatment modality of pediatric patients with Steven Johnson syndrome/toxic epidermal necrolysis: a single-center experience},
journal = {Turkish Journal of Medical Sciences},
year = {2025},
volume = {55},
number = {2},
pages = {461--469},
doi = {10.55730/1300-0144.5990}
}
EUVIMED